Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions

BACKGROUND: Psychiatric medications are widely prescribed in the USA. Many antipsychotics cause serum hyperprolactinemia as an adverse side effect; prolactin-Janus kinase 2 (JAK2)-signal transducer and activator of transcription 5 (STAT5) signaling both induces cell differentiation and suppresses ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, A. N., Bu, W., Hein, S., Garcia, S., Camacho, L., Xue, L., Qin, L., Nagi, C., Hilsenbeck, S. G., Kapali, J., Podsypanina, K., Nangia, J., Li, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960176/
https://www.ncbi.nlm.nih.gov/pubmed/29778097
http://dx.doi.org/10.1186/s13058-018-0969-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960176/
https://www.ncbi.nlm.nih.gov/pubmed/29778097
http://dx.doi.org/10.1186/s13058-018-0969-z

Ejemplares similares